News
Featured Topics
Lead story
Other featured articles
-
Applying to be a USC-AD RCMAR Scientist
Since 2012, the Schaeffer Center has received $6.1 million in funding from the NIH to fund pilot projects by junior scholars focused on addressing disparities. This year we are seeking junior scientists concentrating on Alzheimer’s disease and related dementias in minority populations.
Posted in -
Erin Trish Appointed Co-Director of USC Schaeffer Center
Erin Trish, a health economist whose work focuses on the intersection of public policy and healthcare markets, has been named co-director of the Schaeffer Center.
-
NAS Report Outlines Priorities for the Next Ten Years of Alzheimer’s Research
Julie Zissimopoulos participated on the committee tasked with developing the research agenda.
Posted in -
Experts at Schaeffer-Aspen Webinar Discuss Modernizing Health Technology Assessment in the U.S.
The U.S. does not have a coordinated process to evaluate the effectiveness and value of new devices, medicines or procedures. Schaeffer Center and the Aspen Institute hosted a panel discussion on the viability of an Institute of Health Technology Assessment.
Posted in
Past
-
Precision Medicine: Moving Theory into Practice
Over a four-part webinar series, Schaeffer Center will bring together experts to discuss how we can move precision medicine from theory to practice.
-
USC Study Finds When Medicare Chips in for Hepatitis C Treatment for Medicaid Patients, Everyone Wins
A Medicaid-Medicare partnership could cover lifesaving hepatitis C medications — and still save $1 to $1.1 billion over 25 years
Categorized in -
Applying for the 2022-2023 Roybal Center for Behavioral Interventions in Aging Pilot Projects
The Roybal Center for Behavioral Interventions in Aging seeks proposals for pilot projects that involve randomized controlled trials (RCTs).
-
New Schaeffer Center White Paper Explains Complicated Relationship Between FDA Approvals and Future Innovation
The relationship between approvals and future innovation is unclear at best. As such, the FDA should continue to base its decisions solely on safety and efficacy, rather than speculative long-term innovation effects.
Categorized in -
Roybal Fellow Sparks Winning Nudge to Increase Vaccine Uptake
Jehan Sparks helped design the top-performing “nudge” which resulted in an 11% increase in the rate of flu shot vaccinations.
-
‘Pharmacy Deserts’ Disproportionately Affect Black and Latino Residents in Largest U.S. Cities
Black and Latino neighborhoods in the 30 most populous U.S. cities had fewer pharmacies than white or diverse neighborhoods in 2007-2015, USC research shows, suggesting that ‘pharmacy deserts’ — like so-called food deserts — may be an overlooked contributor to persistent racial and ethnic health disparities.
Categorized in